Medtronic EVP & President Hooman Hakami to Speak at Oppenheimer Healthcare Conference
March 13 2018 - 12:00PM
DUBLIN - March 13, 2018 -
Medtronic plc (NYSE:MDT), the global leader in medical technology,
today announced it will participate in the Oppenheimer
28th Annual
Healthcare Conference on Tuesday, March 20, 2018, in New York
City.
Hooman Hakami, executive vice president and group
president of Medtronic's Diabetes Group, will answer questions
about the company beginning at 8:35 a.m. EDT (7:35 a.m. CDT).
A live audio webcast of the presentation will be
available on March 20, 2018, by clicking on the Investor Events
link at http://investorrelations.medtronic.com. An archive of the
session will be available on the same webpage later in the day.
About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin,
Ireland, is among the world's largest medical technology, services
and solutions companies - alleviating pain, restoring health and
extending life for millions of people around the world. Medtronic
employs more than 84,000 people worldwide, serving physicians,
hospitals and patients in approximately 160 countries. The company
is focused on collaborating with stakeholders around the world to
take healthcare Further, Together.
Any forward-looking statements
are subject to risks and uncertainties such as those described in
Medtronic's periodic reports on file with the Securities and
Exchange Commission. Actual results may differ materially from
anticipated results.
-end-
Contacts:
Fernando Vivanco
Public Relations
+1-763-505-3780
Ryan Weispfenning
Investor Relations
+1-763-505-4626
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Medtronic plc via Globenewswire
Medtronic (NYSE:MDT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medtronic (NYSE:MDT)
Historical Stock Chart
From Apr 2023 to Apr 2024